中华中医药杂志2024,Vol.39Issue(2) :985-988.

《本草纲目·百病主治药》研究述评

Review on the research of Compendium of Materia Medica·Indicative Medicines for Various Diseases

林艳华 宋咏梅
中华中医药杂志2024,Vol.39Issue(2) :985-988.

《本草纲目·百病主治药》研究述评

Review on the research of Compendium of Materia Medica·Indicative Medicines for Various Diseases

林艳华 1宋咏梅1
扫码查看

作者信息

  • 1. 山东中医药大学中医文献与文化研究院,济南 250355
  • 折叠

摘要

"百病主治药"位于《本草纲目》第三、四卷,是李时珍对历代医家辨病与辨证选药精华的总结,有重要的临床应用价值和文献价值.以往对《本草纲目》的研究以药物各论为主,对"百病主治药"的研究较少.近年来,学者对其重视度日益提高,因此文章对"百病主治药"研究成果和存在的问题进行论述,望为日后此部分的研究提供参考.

Abstract

Located in volumes Ⅲ and Ⅳ of the Compendium of Materia Medica,the'indicative medicines for various diseases'was LI Shizhen's summary of the essence of disease differentiation and drug selection by doctors in previous dynasties.It has important clinical application value and literature value.In the past,the research on Compendium of Materia Medica mainly focused on the various theories of drugs,and the research on'indicative medicines for various diseases'was less.In recent years,scholars have paid more and more attention to it.Therefore,this paper discusses the research results and existing problems of'indicative medicines for various diseases',hoping to provide reference for future research in this part.

关键词

《本草纲目》/百病主治药/诸疾通用药/进展/文献研究/以病类药/价值

Key words

Compendium of Materia Medica/Indicative medicines for various diseases/Universal medicine for all diseases/Progress/Literature research/Disease related drugs/Value

引用本文复制引用

基金项目

2020年中医药古籍文献和特色技术传承专项项目(GZY-KJS-2020-029)

出版年

2024
中华中医药杂志
中华中医药学会

中华中医药杂志

CSTPCD北大核心
影响因子:1.135
ISSN:1673-1727
参考文献量34
段落导航相关论文